vs
Side-by-side financial comparison of GLOBAL INDUSTRIAL Co (GIC) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $345.6M, roughly 1.4× GLOBAL INDUSTRIAL Co). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.2%, a 2.6% gap on every dollar of revenue. On growth, GLOBAL INDUSTRIAL Co posted the faster year-over-year revenue change (14.3% vs -1.7%). Over the past eight quarters, GLOBAL INDUSTRIAL Co's revenue compounded faster (3.4% CAGR vs -0.1%).
Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GIC vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $345.6M | $493.8M |
| Net Profit | $14.6M | $33.7M |
| Gross Margin | 34.5% | — |
| Operating Margin | 5.7% | 9.9% |
| Net Margin | 4.2% | 6.8% |
| Revenue YoY | 14.3% | -1.7% |
| Net Profit YoY | 36.4% | 10.5% |
| EPS (diluted) | $0.37 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $345.6M | $493.8M | ||
| Q3 25 | $353.6M | $492.9M | ||
| Q2 25 | $358.9M | $468.8M | ||
| Q1 25 | $321.0M | $458.4M | ||
| Q4 24 | $302.3M | $502.4M | ||
| Q3 24 | $342.4M | $511.2M | ||
| Q2 24 | $347.8M | $504.3M | ||
| Q1 24 | $323.4M | $495.1M |
| Q4 25 | $14.6M | $33.7M | ||
| Q3 25 | $18.8M | $71.7M | ||
| Q2 25 | $25.1M | $39.3M | ||
| Q1 25 | $13.6M | $20.7M | ||
| Q4 24 | $10.7M | $30.5M | ||
| Q3 24 | $16.8M | $19.4M | ||
| Q2 24 | $20.3M | $-153.0M | ||
| Q1 24 | $13.2M | $4.0M |
| Q4 25 | 34.5% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 33.8% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 35.2% | — | ||
| Q1 24 | 34.3% | — |
| Q4 25 | 5.7% | 9.9% | ||
| Q3 25 | 7.4% | 13.8% | ||
| Q2 25 | 9.3% | 12.8% | ||
| Q1 25 | 5.7% | 7.0% | ||
| Q4 24 | 4.8% | 7.8% | ||
| Q3 24 | 6.5% | 6.6% | ||
| Q2 24 | 7.6% | -31.3% | ||
| Q1 24 | 5.4% | 3.2% |
| Q4 25 | 4.2% | 6.8% | ||
| Q3 25 | 5.3% | 14.5% | ||
| Q2 25 | 7.0% | 8.4% | ||
| Q1 25 | 4.2% | 4.5% | ||
| Q4 24 | 3.5% | 6.1% | ||
| Q3 24 | 4.9% | 3.8% | ||
| Q2 24 | 5.8% | -30.3% | ||
| Q1 24 | 4.1% | 0.8% |
| Q4 25 | $0.37 | $0.40 | ||
| Q3 25 | $0.48 | $0.84 | ||
| Q2 25 | $0.65 | $0.46 | ||
| Q1 25 | $0.35 | $0.24 | ||
| Q4 24 | $0.28 | $0.37 | ||
| Q3 24 | $0.44 | $0.23 | ||
| Q2 24 | $0.52 | $-1.84 | ||
| Q1 24 | $0.34 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $67.5M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $313.2M | $865.9M |
| Total Assets | $580.8M | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.5M | $375.2M | ||
| Q3 25 | $67.2M | $340.1M | ||
| Q2 25 | $55.1M | $224.7M | ||
| Q1 25 | $39.0M | $99.0M | ||
| Q4 24 | $44.6M | $229.9M | ||
| Q3 24 | $38.9M | $103.8M | ||
| Q2 24 | $38.8M | $19.4M | ||
| Q1 24 | $29.9M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | — | $583.9M | ||
| Q1 25 | — | $590.5M | ||
| Q4 24 | — | $597.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $313.2M | $865.9M | ||
| Q3 25 | $316.0M | $890.7M | ||
| Q2 25 | $305.2M | $833.8M | ||
| Q1 25 | $287.9M | $789.2M | ||
| Q4 24 | $281.1M | $764.9M | ||
| Q3 24 | $279.2M | $732.5M | ||
| Q2 24 | $270.4M | $706.5M | ||
| Q1 24 | $260.2M | $856.2M |
| Q4 25 | $580.8M | $2.2B | ||
| Q3 25 | $602.5M | $2.2B | ||
| Q2 25 | $586.5M | $2.1B | ||
| Q1 25 | $536.7M | $2.0B | ||
| Q4 24 | $520.7M | $2.2B | ||
| Q3 24 | $531.6M | $2.1B | ||
| Q2 24 | $542.5M | $2.0B | ||
| Q1 24 | $517.4M | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.70× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0M | $114.1M |
| Free Cash FlowOCF − Capex | $19.2M | — |
| FCF MarginFCF / Revenue | 5.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 1.37× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $74.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | $114.1M | ||
| Q3 25 | $22.7M | $137.3M | ||
| Q2 25 | $31.7M | $137.2M | ||
| Q1 25 | $3.4M | $-117.5M | ||
| Q4 24 | $15.9M | $133.0M | ||
| Q3 24 | $9.6M | $91.8M | ||
| Q2 24 | $18.8M | $107.0M | ||
| Q1 24 | $6.4M | $-125.2M |
| Q4 25 | $19.2M | — | ||
| Q3 25 | $22.0M | — | ||
| Q2 25 | $30.3M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $15.2M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $17.9M | — | ||
| Q1 24 | $5.1M | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 8.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 1.37× | 3.39× | ||
| Q3 25 | 1.21× | 1.91× | ||
| Q2 25 | 1.26× | 3.49× | ||
| Q1 25 | 0.25× | -5.66× | ||
| Q4 24 | 1.49× | 4.36× | ||
| Q3 24 | 0.57× | 4.72× | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.48× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GIC
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
